Structural basis for a class of nanomolar influenza A neuraminidase inhibitors

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Kerry, Philip S ^a   Mohan, Sankar ^a   Russell, Rupert J M ^b   Bance, Nicole ^b   Niikura, Masahiro ^b   Mario Pinto, B ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ENZYME INHIBITOR; OSELTAMIVIR; SIALIDASE; VIRUS PROTEIN;

ANIMAL; ANTIVIRAL RESISTANCE; ARTICLE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVE SITE; ENZYMOLOGY; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; METABOLISM; MICROBIAL SENSITIVITY TEST; PROTEIN BINDING;

ANIMALS; ANTIVIRAL AGENTS; CATALYTIC DOMAIN; CELL LINE; DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; NEURAMINIDASE; OSELTAMIVIR; PROTEIN BINDING; VIRAL PROTEINS;

EID: 84893254796     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02871     Document Type: Article

References (29)

1. Influenza fact sheet No. 211: World Health Organization; (2009)
2. Air, G. M. Influenza neuraminidase. Influenza Other Respi Viruses. 6(4), 245-256 (2012)
3. Tong, S. et al. A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A. 109(11), 4269-4274 (2012)
4. Russell, R. J. et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature. 443(7107), 45-49 (2006)
5. Zhu, X. et al. Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site. Proc Natl Acad Sci U S A. 109(46), 18903-18908 (2012)
6. Li, Q. et al. Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus. Proc Natl Acad Sci U S A. 109(46), 18897-18902 (2012)
7. van der Vries, E. et al. H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. PLoS Pathog. 8(9), e1002914 (2012)
8. Amaro, R. E. et al. Mechanism of 150-cavity formation in influenza neuraminidase. Nat Commun. 2, 388 (2011)
9. Li, Q. et al. The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site. Nat Struct Mol Biol. 17(10), 1266-1268 (2010)
10. Han, N. &Mu, Y. Plasticity of 150-loop in influenza neuraminidase explored by hamiltonian replica exchange molecular dynamics simulations. PLoS One. 8(4), e60995 (2013)
11. Rudrawar, S. et al. Synthesis and evaluation of novel 3-C-Alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility. Org Biomol Chem. 10(43), 8628-8639 (2012)
12. Rudrawar, S. et al. Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase. Nat Commun. 1, 113 (2010)
13. Mohan, S., McAtamney, S., Haselhorst, T., von Itzstein, M. &Pinto, B. M. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles. J Med Chem. 53(20), 7377-7391 (2010)
14. Wen, W. H. et al. Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses. Bioorg Med Chem. 18(11), 4074-4084 (2010)
15. Greenway, K. T., LeGresley, E. B. &Pinto, B. M. The influence of 150-cavity binders on the dynamics of influenza A neuraminidases as revealed by molecular dynamics simulations and combined clustering. PLoS One. 8(3), e59873 (2013)
16. Amaro, R. E., Cheng, X., Ivanov, I., Xu, D. &McCammon, J. A. Characterizing loop dynamics and ligand recognition in human-And avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations. J Am Chem Soc. 131(13), 4702-4709 (2009)
17. Wu, Y. et al. Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding. Sci Rep. 3, 1551 (2013)
18. Niikura, M., Bance, N., Mohan, S. &Pinto, B. M. Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro. Antiviral Res. 90(3), 160-163 (2011)
19. Albohy, A., Mohan, S., Zheng, R. B., Pinto, B. M. &Cairo, C. W. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes. Bioorg Med Chem. 19(9), 2817-2822 (2011)
20. Hata, K. et al. Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob Agents Chemother. 52(10), 3484-3491 (2008)
21. Gubareva, L. V., Webster, R. G. &Hayden, F. G. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother. 45(12), 3403-3408 (2001)
22. Collins, P. J. et al. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature. 453(7199), 1258-1261 (2008)
23. von Itzstein, M. et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 363(6428), 418-423 (1993)
24. Shie, J. J. et al. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity. J Am Chem Soc. 129(39), 11892-11893 (2007)
25. Smee, D. F., Morrison, A. C., Barnard, D. L. &Sidwell, R. W. Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. J Virol Methods. 106(1), 71-79 (2002)
26. Smee, D. F., Huffman, J. H., Morrison, A. C., Barnard, D. L. &Sidwell, R. W. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrob Agents Chemother. 45(3), 743-748 (2001)
27. Otwinowski, Z. &Minor, W. In: Sawyer, L., Isaacs, N., Bailey, S. (eds). Data Collection and Processing. 556-562 (SERC Daresbury Laboratory: Warrington, 1993)
28. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 66(Pt 2), 213-221 (2010)
29. Emsley, P., Lohkamp, B., Scott, W. G. &Cowtan, K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 66(Pt 4), 486-501 (2010)